Cargando…
Comparative functional genomics of the acarbose producers reveals potential targets for metabolic engineering
The α-glucosidase inhibitor acarbose is produced in large-scale by strains derived from Actinoplanes sp. SE50 and used widely for the treatment of type-2 diabetes. Compared with the wild-type SE50, a high-yield derivative Actinoplanes sp. SE50/110 shows 2-fold and 3–7-fold improvement of acarbose yi...
Autores principales: | Xie, Huixin, Zhao, Qinqin, Zhang, Xin, Kang, Qianjin, Bai, Linquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350373/ https://www.ncbi.nlm.nih.gov/pubmed/30723817 http://dx.doi.org/10.1016/j.synbio.2019.01.001 |
Ejemplares similares
-
A severe leakage of intermediates to shunt products in acarbose biosynthesis
por: Zhao, Qinqin, et al.
Publicado: (2020) -
Improving acarbose production and eliminating the by-product component C with an efficient genetic manipulation system of Actinoplanes sp. SE50/110
por: Zhao, Qinqin, et al.
Publicado: (2017) -
Biosynthesis of ansamitocin P-3 incurs stress on the producing strain Actinosynnema pretiosum at multiple targets
por: Huang, Qungang, et al.
Publicado: (2023) -
Subtilisin-Involved Morphology Engineering for Improved Antibiotic Production in Actinomycetes
por: Wu, Yuanting, et al.
Publicado: (2020) -
On the potential of acarbose to reduce cardiovascular disease
por: Standl, Eberhard, et al.
Publicado: (2014)